P

Inventor

DENNIS MARK

US46 patents
⚠️ This page may combine multiple inventors who share the name “DENNIS MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENENTECH INC

28 patents
US9896506B2Feb 20, 2018

Anti-CD79B antibodies and immunoconjugates and methods of use

GENENTECH INC17 citations94
US9518118B2Dec 13, 2016

Anti-HER2 antibodies and immunoconjugates

GENENTECH INC22 citations92
US9611323B2Apr 4, 2017

Low affinity blood brain barrier receptor antibodies and uses therefor

GENENTECH INC40 citations90
US10494432B2Dec 3, 2019

Anti-CD79B antibodies and immunoconjugates and methods of use

GENENTECH INC5 citations84
US10179820B2Jan 15, 2019

Anti-HER2 antibodies and immunoconjugates

GENENTECH INC6 citations83
US8771966B2Jul 8, 2014

Immuno-PET imaging of antibodies and immunoconjugates and uses therefor

GENENTECH INC17 citations83
US10752703B2Aug 25, 2020

Anti-tryptase antibodies, compositions thereof, and uses thereof

GENENTECH INC7 citations81
US10941215B2Mar 9, 2021

Low affinity blood brain barrier receptor antibodies and uses thereof

GENENTECH INC6 citations79
US11866496B2Jan 9, 2024

Humanized anti-CD79B antibodies and immunoconjugates and methods of use

GENENTECH INC1 citations73
USRE48558EMay 18, 2021

Anti-CD79B antibodies and immunoconjugates and methods of use

GENENTECH INC2 citations73
US10981987B2Apr 20, 2021

Humanized anti-CD79b antibodies and immunoconjugates and methods of use

GENENTECH INC4 citations73
US10544218B2Jan 28, 2020

Anti-CD79B antibodies and immunoconjugates and methods of use

GENENTECH INC4 citations73
US9266955B2Feb 23, 2016

Anti-FGFR4 antibodies and methods of use

GENENTECH INC5 citations73
US10556966B2Feb 11, 2020

Anti-HER2 antibodies and immunoconjugates

GENENTECH INC2 citations72
US10314846B2Jun 11, 2019

Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepines

GENENTECH INC2 citations72
US9719996B2Aug 1, 2017

Anti-mesothelin antibodies and immunoconjugates

GENENTECH INC2 citations72
US11939396B2Mar 26, 2024

Anti-tryptase antibodies, compositions thereof, and uses thereof

GENENTECH INC1 citations70
US10738131B2Aug 11, 2020

Anti-tryptase antibodies, compositions thereof, and uses thereof

GENENTECH INC2 citations70
US12583937B2Mar 24, 2026

Compositions and methods for the diagnosis and treatment of tumor

GENENTECH INC0 citations62
US12492263B2Dec 9, 2025

Anti-HER2 antibodies and immunoconjugates

GENENTECH INC0 citations62
US10377825B2Aug 13, 2019

Anti-HER2 antibodies and methods of use

GENENTECH INC1 citations59
US9994643B2Jun 12, 2018

Compositions and methods for the diagnosis and treatment of tumor

GENENTECH INC0 citations52
US9029511B2May 12, 2015

Compositions and methods for the diagnosis and treatment of tumor

GENENTECH INC0 citations52
US8871911B2Oct 28, 2014

Compositions and methods for the diagnosis and treatment of tumor

GENENTECH INC0 citations52
US10022452B2Jul 17, 2018

Anti-mesothelin antibodies and immunoconjugates

GENENTECH INC0 citations51
US10633650B2Apr 28, 2020

Expression and secretion system

GENENTECH INC0 citations50
US9803191B2Oct 31, 2017

Expression and secretion system

GENENTECH INC0 citations50
US11167038B2Nov 9, 2021

Methods for improving safety of blood-brain barrier transport

GENENTECH INC0 citations45

CHEN YVONNE

5 patents

DENNIS MARK

4 patents

WU LAWREN

4 patents

PNC GLOBAL TRANSFERS INC

3 patents

YE WEILAN

1 patent

BBVA TRANSFER SERVICES INC

1 patent